These companies could be at the forefront of a potential US manufacturing resurgence that hasn't been seen in decades. If Trump's tariff strategy works, they might be positioned for substantial growth.
We're witnessing the biggest change to global trade policies since 1930. Getting in early on the right companies could mean capturing value from this historic economic realignment.
With foreign competition potentially reduced, these American companies might gain market share and pricing power in their industries. They're selected from sectors specifically targeted for protection.
President Trump has implemented widespread tariffs on imports from major trading partners like China, Europe, and Canada. This collection focuses on US companies that could benefit if these protectionist policies successfully reduce foreign competition and strengthen domestic manufacturing.
These tariffs represent the biggest shake-up to global trade in nearly a century. While they've initially caused market volatility, they could create opportunities for US companies in steel, aluminum, auto manufacturing, semiconductors, and retail with strong domestic supply chains.
We've handpicked companies across key sectors targeted by Trump's policy - from industrial manufacturers to technology firms. These selections represent businesses that might gain competitive advantages if the tariffs achieve their intended goals of reviving US manufacturing and employment.
Summary and investor key takeaways for the provided basket market capitalisation breakdown.
NUE: $32.25B
AA: $9.64B
CAT: $245.79B
Here are a few of the assets in this group. Create an account to unlock the full list.
이 바스켓의 전체 스토리를 확인하세요. 리스크와 잠재력을 다룬 상세 기사를 읽어보세요.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Earn 6% AER on uninvested cash with daily interest payments.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
이 자산들에 투자했다면:
12개월 후 예상 가치:
+1.78%
애널리스트들은 이 그룹의 자산이 향후 1년간 평균 1.78% 성장할 것으로 예상합니다.
이 그룹의 자산 10개 중 8개가 전문 애널리스트로부터 매수 의견을 받았습니다.
